The evaluation of the relapse-free survival rate in the prostate cancer patient who received a focal brachytherapy.
Not Applicable
Recruiting
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000026449
- Lead Sponsor
- Tokyo Metropolitan Police Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients must not be under these conditions 1) Patients who had past surgical histories of benign prostatic hyperplasia. 2) Patients who had severe mental disorders. 3) Patients who had other active cancers 4) Patients who doctors judge as unsuitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method biochemical relapse-free survival rates by using the Phoenix definition Clinical relapse-free survival rates by using the imaging evaluation by the magnetic resonance imaging after 1 and 4 years of the treatment and the repeat biopsy after 3 year
- Secondary Outcome Measures
Name Time Method disease-specific survival rates